R&D $1,182,000 and Marketing $219,000 for the quarter.
But JS had said "We have moved from a development company to a sales company" (or words to that effect).
What is going on? IMO, they should concentrate on selling whatever is their best(= most marketable) product. The R&D should be 219k and the Marketing 219M.
- Forums
- ASX - By Stock
- UBI
- Ann: December 2023 Quarterly Activity Report and Appendix 4C
UBI
universal biosensors inc.
Add to My Watchlist
4.76%
!
2.0¢

Ann: December 2023 Quarterly Activity Report and Appendix 4C, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $5.961M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.0¢ | $10.03K | 489.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2323 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 75003 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2323 | 0.020 |
1 | 52680 | 0.019 |
3 | 181600 | 0.018 |
2 | 72000 | 0.017 |
2 | 108880 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 75003 | 1 |
0.025 | 128817 | 1 |
0.030 | 18543 | 1 |
0.048 | 100000 | 1 |
0.050 | 102561 | 2 |
Last trade - 15.06pm 04/07/2025 (20 minute delay) ? |
Featured News
UBI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online